Most not too long ago, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds into a big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts as being a scavenger and would not act